Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
<p>Abstract</p> <p>Background</p> <p>Estimates of the prevalence of transmitted HIV drug resistance (TDR) in a population are derived from resistance tests performed on samples from patients thought to be naïve to antiretroviral treatment (ART). Much of the debate over...
Main Authors: | Castro Hannah, Pillay Deenan, Sabin Caroline, Dunn David T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | BMC Medical Research Methodology |
Online Access: | http://www.biomedcentral.com/1471-2288/12/30 |
Similar Items
-
Transmitted antiretroviral drug resistance in a low HIV prevalence setting
by: Nguyen, Thuy Thi Vu
Published: (2012) -
Population dynamics in HIV-1 transmitted antiretroviral drug resistance
by: Harris, Dean Mark
Published: (2018) -
Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999–2014
by: Annette M. Aldous, et al.
Published: (2017-09-01) -
Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.
by: Barbara Bartmeyer, et al.
Published: (2010-10-01) -
National prevalence and trends of HIV transmitted drug resistance in Mexico.
by: Santiago Avila-Ríos, et al.
Published: (2011-01-01)